{"id":"W2127783189","doi":"10.1158/1078-0432.ccr-08-2076","title":"A Phase I Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Deforolimus in Patients with Advanced Malignancies","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Mucositis; Tolerability; Pharmacokinetics; Medicine; Toxicity; Dosing; Pharmacodynamics; Pharmacology; Internal medicine; Phases of clinical research; Gastroenterology; Adverse effect; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000868268,0.0007844002,0.001053535,0.000219431,0.0002852527,0.0003256931,0.0004081795,0.0006662396,0.00226064],"category_scores_gemma":[0.000617051,0.0002485147,0.0004869588,0.0002279337,0.0005276893,0.0004020164,0.0002073034,0.001392134,0.0003286319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004589556,"about_ca_system_score_gemma":0.0008743973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000328704,"about_ca_topic_score_gemma":0.0006324265,"domain_scores_codex":[0.9997368,0.0001405277,0.00001463295,0.00003784338,0.00002412658,0.00004608278],"domain_scores_gemma":[0.9994388,0.0001248216,0.0001466308,0.00003379701,0.0000235052,0.0002323541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6388945,0.04564056,0.01490299,0.001001009,0.0006119518,0.0004617942,0.000379256,0.003379482,0.1323843,0.0004360024,0.003673308,0.1582348],"study_design_scores_gemma":[0.402997,0.566375,0.01714982,0.00003763807,0.0002040079,0.0005338073,0.00003951393,0.001666871,0.008496892,0.0001512247,0.002322864,0.00002526804],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962285,0.00114013,0.0004339606,0.0002158873,0.0000466181,0.001023122,0.0002122235,0.0000336661,0.0006659013],"genre_scores_gemma":[0.9939885,0.0007085436,0.00185823,0.000412875,0.0001373746,0.001385988,0.0007659236,0.00001168143,0.0007309899],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00226064,"threshold_uncertainty_score":0.007562518,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08724902439158091,"score_gpt":0.4557811363761681,"score_spread":0.3685321119845872,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}